VAT Rates and Coding Matching for Medical Devices in Russia

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Preferential value-added tax rates apply in Russia to certain medical devices. The 0% rate applies to products on the list approved by Government Resolution No. 1042 of 30 September 2015, the 10% rate applies to products on the list approved by Government Resolution No. 688 of 15 September 2008, and products not on either list are taxed at the standard rate applicable at the time of the customs declaration. Enjoying the preference requires a double match: the customs classification code under TN VED and the OKPD 2 code stated in the registration documents must be consistent with each other and with the list entry. The preference is therefore never decided by the product name alone; it is decided by the alignment of two code systems across two separate document sets, one prepared for customs and one prepared for registration years earlier.

Because VAT is charged on every shipment and the double match is tested repeatedly over the life of the certificate, coding is not a one-time registration question but a permanent trade compliance variable. A mismatch discovered after years of imports converts a routine clearance into a tax recovery exercise, with interest, across the whole historical volume. The coding decision made in the registration phase silently sets the tax economics of every later shipment, and it does so in a way that is easy to overlook: the OKPD 2 code sits in a technical registration document, far from the finance systems where the rate is actually applied, and only a deliberate reconciliation between the two brings inconsistencies to light before they become expensive.

2. Legal basis

The two preferential lists, the statutory rate framework and the judicial requirement of code consistency form the legal foundation of the VAT treatment of medical devices. The table below lists the instruments relied on in this article, with reference numbers, dates and relevant provisions.

Legal actReferenceDateProvisions
Government Resolution of the Russian Federation (0% VAT list)Government Resolution No. 104230 September 2015the list and the conditions of its application
Government Resolution of the Russian Federation (10% VAT list)Government Resolution No. 68815 September 2008the list and the conditions of its application
Tax Code of the Russian FederationTax Code of the Russian Federation (Part Two)current versionVAT rates and rules of application
Ruling of the Supreme Court of the Russian FederationRuling No. АКПИ16-28925 May 2016requirement of consistency between the commodity codes
Government Resolution of the Russian Federation (parallel import)Government Resolution No. 50629 March 2022parallel import list (medical devices are essentially not included)

3. Expert insights

Insight one: the list and the codes are two different filters. Finding the product name on a list is not sufficient. Customs classifies goods by the TN VED code declared at the border, while the tax authority and other verification bodies check the OKPD 2 code stated in the registration documents. The ruling of the Supreme Court of the Russian Federation of 25 May 2016, No. АКПИ16-289, turned precisely on this question of cross-consistency. A product can clear one filter and fail the other, so both must be engineered together, and the alignment must be documented before the first preferential declaration is filed.

Insight two: the price of a classification error is a retrospective recovery. Once a preference is denied, the tax is reclaimed with late-payment penalties, and because the look-back period is long, this risk often surfaces only in the second year of sales, when the cumulative amounts are at their largest. The commercial model built on the preferential rate then has to be renegotiated with finance at the worst possible moment. Preventing the error is cheaper by orders of magnitude than defending it.

Insight three: the coding work must be completed before shipment. The standard rate is applied at the moment of the customs declaration, and by that point the OKPD 2 code must already be confirmed in the registration documents. If the code was omitted or recorded inconsistently at the registration stage, correcting it later is a dossier change procedure, with its own timeline and fees. The sequencing rule is simple: confirm the code in the registration file, then lock the commercial documents to it, and only then ship.

Insight four: the lists are living documents. Both Government Resolution No. 1042 and Government Resolution No. 688 are amended over time, and the standard rate itself can change. A quarterly review of the list revisions and the current standard rate, recommended below, keeps the three-field mapping current and prevents a model from drifting between preference and standard taxation without anyone noticing.

4. Practical recommendations

The measures below keep the VAT treatment of each model stable and defensible across the import cycle. They apply to regulatory, customs and finance teams working from the same product portfolio.

  1. Maintain a three-field mapping table for every model: TN VED code, OKPD 2 code and applicable VAT rate.
  2. For new models, record the OKPD 2 code in the technical documentation at the registration stage and carry it into subsequent commercial invoices.
  3. Review the amendments to both lists and the current standard rate quarterly, and update the mapping table whenever a change affects a model.
  4. Keep the product names and models in commercial invoices and contracts identical to those in the registration documents.

5. Verification checklist

Confirm each item below before the next declaration is filed. The checklist covers the mapping, the list status, the code consistency and the document alignment.

  • □ The three-field coding mapping table has been established and is updated with the model list
  • □ The product has been confirmed to fall within the 0% or 10% list
  • □ The customs TN VED code and the OKPD 2 code in the registration documents are consistent
  • □ The product names and models in commercial invoices and contracts match the registration documents
  • □ The current standard rate and the revision status of the lists have been rechecked

Regulatory information verified as of 29 October 2026.

GRZAN supports the tax and customs side of medical device imports in Russia: building TN VED and OKPD 2 mapping tables, aligning registration documents with commercial invoices, and monitoring revisions of the preferential VAT lists so that the double match holds on every declaration. For a VAT classification review, contact GRZAN at info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail